Blythe Adamson, PhD, MPH
Health Economist · Policy Advisor · Data Scientist
Where does a dollar, a drug, or an AI tool create the most value and health for society & why do we keep getting it wrong?
Expertise That Moves Markets and Saves Lives
Four pillars of impact anchored by high-stakes decision-making under uncertainty.
High-Stakes Decision-Making
The scientist who leaders call when the data is uncertain and the stakes are real, from advising the President on pandemic strategy to helping AI organizations prioritize where to create the most health value for society.
Proving What Works & What It’s Worth
Building the economic evidence that drugs, AI tools, vaccines, and policies need to justify their price and secure reimbursement. Crafting payer value stories across jurisdictions.
Real-World Evidence
Turning messy, real-world patient data (EHR, claims, and more) into rigorous evidence. Unique international depth across Europe and Japan, navigating GDPR, APPI, and local-language clinical documentation.
Speaking & Thought Leadership
International keynotes on high-stakes decision-making under uncertainty, accessible science writing, and ideas en route to a TED stage.
As Seen In
The White House / C-SPAN · CNBC · BBC · Bloomberg · GMA · MSNBC · Fox Business · NPR · The Atlantic · Vanity Fair · Rolling Stone · The New York Times · USA Today · Business Insider
The Scientist Who Leaders Call for High-Stakes Decisions
From advising the President during COVID-19 to evaluating AI systems for cancer care across four countries, I’ve spent my career at the intersection of health economics, data science, and policy — building the evidence base that moves both markets and medicine.
Through Infectious Economics, I work with government agencies, pharmaceutical companies, AI organizations, and financial services firms navigating complex decisions where the data is uncertain and the stakes are real.

Ready to Work Together?
Whether you need strategic advisory, economic modeling, expert testimony, or a keynote speaker who can translate complex science for any audience.